Search

Andrew J. Steinle

Examiner (ID: 11228, Phone: (571)272-9923 , Office: P/2497 )

Most Active Art Unit
2497
Art Unit(s)
2497
Total Applications
793
Issued Applications
704
Pending Applications
65
Abandoned Applications
65

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 7200447 [patent_doc_number] => 20050165010 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-28 [patent_title] => 'Use of substituted pteridines for the treatment of respiratory diseases' [patent_app_type] => utility [patent_app_number] => 11/034281 [patent_app_country] => US [patent_app_date] => 2005-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4109 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20050165010.pdf [firstpage_image] =>[orig_patent_app_number] => 11034281 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/034281
Use of substituted pteridines for the treatment of respiratory diseases Jan 11, 2005 Abandoned
Array ( [id] => 7168103 [patent_doc_number] => 20050201949 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-15 [patent_title] => 'Pharmaceutical formulations' [patent_app_type] => utility [patent_app_number] => 11/023015 [patent_app_country] => US [patent_app_date] => 2004-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4050 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0201/20050201949.pdf [firstpage_image] =>[orig_patent_app_number] => 11023015 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/023015
Pharmaceutical formulations Dec 20, 2004 Abandoned
10/991573 Methods and compositions for the treatment of metabolic disorders Nov 16, 2004 Abandoned
Array ( [id] => 7020117 [patent_doc_number] => 20050222136 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-06 [patent_title] => 'Active substance combination' [patent_app_type] => utility [patent_app_number] => 10/987803 [patent_app_country] => US [patent_app_date] => 2004-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11883 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0222/20050222136.pdf [firstpage_image] =>[orig_patent_app_number] => 10987803 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/987803
Active substance combination Nov 11, 2004 Abandoned
Array ( [id] => 7111685 [patent_doc_number] => 20050209141 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-22 [patent_title] => 'Mast cell-derived renin' [patent_app_type] => utility [patent_app_number] => 10/964567 [patent_app_country] => US [patent_app_date] => 2004-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 22636 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20050209141.pdf [firstpage_image] =>[orig_patent_app_number] => 10964567 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/964567
Mast cell-derived renin Oct 12, 2004 Abandoned
Array ( [id] => 6997440 [patent_doc_number] => 20050137218 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-23 [patent_title] => 'Treatment of pancreatitis using alpha 7 receptor-binding cholinergic agonists' [patent_app_type] => utility [patent_app_number] => 10/957426 [patent_app_country] => US [patent_app_date] => 2004-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 12753 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20050137218.pdf [firstpage_image] =>[orig_patent_app_number] => 10957426 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/957426
Treatment of pancreatitis using alpha 7 receptor-binding cholinergic agonists Sep 29, 2004 Issued
Array ( [id] => 7216091 [patent_doc_number] => 20050054614 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-10 [patent_title] => 'Methods of inhibiting leukocyte accumulation' [patent_app_type] => utility [patent_app_number] => 10/918825 [patent_app_country] => US [patent_app_date] => 2004-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19641 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20050054614.pdf [firstpage_image] =>[orig_patent_app_number] => 10918825 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/918825
Methods of inhibiting leukocyte accumulation Aug 12, 2004 Abandoned
Array ( [id] => 5739033 [patent_doc_number] => 20060009424 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-12 [patent_title] => 'Nasaleaze' [patent_app_type] => utility [patent_app_number] => 10/710382 [patent_app_country] => US [patent_app_date] => 2004-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 89 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20060009424.pdf [firstpage_image] =>[orig_patent_app_number] => 10710382 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/710382
Nasaleaze Jul 5, 2004 Abandoned
Array ( [id] => 7122970 [patent_doc_number] => 20050014799 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-20 [patent_title] => 'Pyridoxamine for the treatment of diabetic kidney disease' [patent_app_type] => utility [patent_app_number] => 10/871224 [patent_app_country] => US [patent_app_date] => 2004-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 4617 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20050014799.pdf [firstpage_image] =>[orig_patent_app_number] => 10871224 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/871224
Pyridoxamine for the treatment of diabetic kidney disease Jun 17, 2004 Abandoned
Array ( [id] => 7427353 [patent_doc_number] => 20040229876 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-18 [patent_title] => 'Quinoline derivatives and quinazoline derivatives having azolyl group' [patent_app_type] => new [patent_app_number] => 10/861446 [patent_app_country] => US [patent_app_date] => 2004-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24168 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20040229876.pdf [firstpage_image] =>[orig_patent_app_number] => 10861446 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/861446
Quinoline derivatives and quinazoline derivatives having azolyl group Jun 6, 2004 Issued
Array ( [id] => 7155913 [patent_doc_number] => 20050026852 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-03 [patent_title] => 'Method of augmenting the antitumor activity of anticancer agents' [patent_app_type] => utility [patent_app_number] => 10/844800 [patent_app_country] => US [patent_app_date] => 2004-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 4395 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0026/20050026852.pdf [firstpage_image] =>[orig_patent_app_number] => 10844800 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/844800
Method of augmenting the antitumor activity of anticancer agents May 12, 2004 Abandoned
Array ( [id] => 7256442 [patent_doc_number] => 20040259863 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-23 [patent_title] => 'Type 4 phosphodiesterase inhibitors and uses thereof' [patent_app_type] => new [patent_app_number] => 10/494379 [patent_app_country] => US [patent_app_date] => 2004-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19422 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0259/20040259863.pdf [firstpage_image] =>[orig_patent_app_number] => 10494379 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/494379
Type 4 phosphodiesterase inhibitors and uses thereof Apr 29, 2004 Abandoned
Array ( [id] => 7105170 [patent_doc_number] => 20050107349 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-19 [patent_title] => 'Method for the treatment or prevention of respiratory disorders with a cyclooxygenase-2 inhibitor in combination with a muscarinic receptor antagonist and compositions therewith' [patent_app_type] => utility [patent_app_number] => 10/833658 [patent_app_country] => US [patent_app_date] => 2004-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44728 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20050107349.pdf [firstpage_image] =>[orig_patent_app_number] => 10833658 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/833658
Method for the treatment or prevention of respiratory disorders with a cyclooxygenase-2 inhibitor in combination with a muscarinic receptor antagonist and compositions therewith Apr 27, 2004 Abandoned
Array ( [id] => 7409987 [patent_doc_number] => 20040176323 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-09 [patent_title] => 'Pharmaceutical composition comprising lysophophatidic acid' [patent_app_type] => new [patent_app_number] => 10/475814 [patent_app_country] => US [patent_app_date] => 2004-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2621 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20040176323.pdf [firstpage_image] =>[orig_patent_app_number] => 10475814 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/475814
Pharmaceutical composition comprising lysophophatidic acid Apr 21, 2004 Abandoned
10/493207 Medicament comprising combination of triazaspiro[5.5]undecane derivative with cytochrome p450 isozyme 3a4 inhibitor and/or p-glycoprotein inhibitor Apr 19, 2004 Abandoned
Array ( [id] => 7433893 [patent_doc_number] => 20040209916 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-21 [patent_title] => 'Combination therapies' [patent_app_type] => new [patent_app_number] => 10/824315 [patent_app_country] => US [patent_app_date] => 2004-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11262 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20040209916.pdf [firstpage_image] =>[orig_patent_app_number] => 10824315 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/824315
Combination therapies Apr 12, 2004 Abandoned
Array ( [id] => 7432842 [patent_doc_number] => 20040162294 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-19 [patent_title] => 'Therapeutic use of selective PDE10 inhibitors' [patent_app_type] => new [patent_app_number] => 10/779212 [patent_app_country] => US [patent_app_date] => 2004-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10048 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20040162294.pdf [firstpage_image] =>[orig_patent_app_number] => 10779212 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/779212
Therapeutic use of selective PDE10 inhibitors Feb 12, 2004 Abandoned
Array ( [id] => 7432832 [patent_doc_number] => 20040162293 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-19 [patent_title] => 'Therapeutic use of selective PDE10 inhibitors' [patent_app_type] => new [patent_app_number] => 10/778809 [patent_app_country] => US [patent_app_date] => 2004-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9599 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20040162293.pdf [firstpage_image] =>[orig_patent_app_number] => 10778809 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/778809
Therapeutic use of selective PDE10 inhibitors Feb 12, 2004 Abandoned
Array ( [id] => 7150909 [patent_doc_number] => 20040171556 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-02 [patent_title] => 'Methods for inhibiting proteasome' [patent_app_type] => new [patent_app_number] => 10/761990 [patent_app_country] => US [patent_app_date] => 2004-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26478 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20040171556.pdf [firstpage_image] =>[orig_patent_app_number] => 10761990 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/761990
Methods for inhibiting proteasome Jan 20, 2004 Abandoned
Array ( [id] => 7672861 [patent_doc_number] => 20040180918 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-16 [patent_title] => 'Novel therapeutic method' [patent_app_type] => new [patent_app_number] => 10/484292 [patent_app_country] => US [patent_app_date] => 2004-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4597 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20040180918.pdf [firstpage_image] =>[orig_patent_app_number] => 10484292 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/484292
Novel therapeutic method Jan 19, 2004 Abandoned
Menu